Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo

Ipriflavone, a synthetic isoflavone that inhibits osteoclastic bone resorption, has been used clinically for the treatment of osteoporosis. However, the anticancer activity of Ipriflavone and its molecular mechanisms in the context of esophageal squamous cell carcinoma (ESCC) have not been investiga...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Oncol
Hauptverfasser: Shi, Xiaodan, Zhang, Yuanyuan, Xie, Xiaomeng, Pang, Mengjun, Laster, Kyle, Li, Jian, Ma, Xinli, Liu, Kangdong, Dong, Zigang, Kim, Dong Joon
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2021
Schlagworte:
Oncology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8222593/
https://ncbi.nlm.nih.gov/pubmed/34178634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.648809
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge